Stockreport

Kairos Pharma Closing of $6.2 Million Initial Public Offering

Kairos Pharma, Ltd.  (KAPA) 
PDF LOS ANGELES, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Kairos Pharma, Ltd. (“Kairos Pharma” or the “Company”) (NYSE American: KAPA), a clinical stage biopharmaceutical compan [Read more]